Status:
COMPLETED
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Conditions:
Atrial Fibrillation
Atrial Tachycardia
Eligibility:
All Genders
Brief Summary
Aims Amiodarone is the gold-standard medication to control heart rate in critically ill patients with atrial tachyarrhythmias (ATs); however, effective doses and covariates influencing its efficacy re...
Eligibility Criteria
Inclusion
- critically ill patients who had received at least one dose of amiodarone to treat or prevent AT during their hospitalization in the ICU.
Exclusion
- Patients with paced rhythm or incomplete charts were excluded
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03413150
Start Date
January 1 2007
End Date
April 1 2012
Last Update
September 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.